Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Cardiology
Atherosclerotic Disease
Atrial Fibrillation
Heart Failure
Hypertension
Interventional Cardiology
Lipid Management
Practice Tips With Dr. Lichaa
Preventive Cardiology
Stroke
Oncology
Breast Cancer
Gynecologic Cancer
Head and Neck Cancer
Skin Cancer
Sleep
Urology
More
Diabetes
Ophthalmology
— Demodex Blepharitis
Neurology
Rheumatology
Gastroenterology
Pulmonology
Infectious Diseases
— HIV
Health and Wellness
Lupus
Future of Medicine
Orthopedics
Pharmacology
Career News
Suneel Kamath, MD
Suneel Kamath, MD, of Cleveland Clinic
Articles by Suneel Kamath, MD
Antibody-Drug Conjugates and Immunotherapy Combinations: What is Next?
Nataliya Uboha, MD, PhD
GI Cancer
|
March 13, 2025
The panel covers ASPEN-O6 results, excitement around ADCs in late-line HER-2 and Claudin-positive cancers, and more.
View More
Exploring Tislelizumab and Zolbetuximab: Immunotherapy and Targeted Options in Gastric Cancer
Nataliya Uboha, MD, PhD
GI Cancer
|
March 13, 2025
The panel considers tislelizumab amid existing PD-1 inhibitors, zolbetuximab for Claudin-positive patients, and more.
View More
Navigating Adjuvant Therapies in Early-Stage Esophageal Cancer: The Role of IO and MRD Testing
Nataliya Uboha, MD, PhD
GI Cancer
|
March 13, 2025
The panel covers updates on 1L treatments for metastatic gastric cancer, including the recent approval of tislelizumab.
View More
Evolving Strategies for Early-Stage Esophageal Cancer: FLOT, CROSS, and Immunotherapy
Nataliya Uboha, MD, PhD
GI Cancer
|
March 13, 2025
The panel explores advancements in early-stage esophageal cancer, emphasizing the paradigm shift toward FLOT chemotherapy.
View More
Personalized Care in Gastric and Esophageal Cancers: Biomarkers, Diagnosis, and Treatment Approaches
Nataliya Uboha, MD, PhD
GI Cancer
|
March 13, 2025
The panel focuses on the management of gastroesophageal cancers, highlighting differences in presentations across regions.
View More
Future Directions in Colorectal Cancer Care
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel concludes with the challenges of implementing cutting-edge research into colorectal cancer care and practice.
View More
Sequencing Novel Therapies in Colorectal Cancer
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel explores sequencing challenges for therapies like fruquintinib, TAS-102, and sotorasib for colorectal cancer.
View More
Incorporating ctDNA, Novel Therapies Into Practice for Colorectal Cancer
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel expands on the incorporation of ctDNA in the CRC adjuvant setting, highlighting its prognostic value.
View More
Treatment Considerations for Oligometastatic Colorectal Cancer
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel details strategies for managing oligometastatic CRC, emphasizing the importance of a multidisciplinary approach.
View More
Targeted Therapies and Drivers for Treatment Choice in Colorectal Cancer
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel swaps opinions on advancements in EGFR and KRAS inhibitors, as well as the importance of NGS and liquid biopsy.
View More
Colorectal Cancer: Recent Changes in the Treatment Landscape
Shikha Jain, MD, FACP
Colorectal Cancer
|
March 13, 2025
The panel focuses on the evolution of CRC treatment paradigms, including advances in chemo, biologic agents, and more.
View More